Total synthesis and structure of the ramoplanin A1 and A3 aglycons: Two minor components of the ramoplanin complex

被引:29
作者
Shin, D
Rew, Y
Boger, DL
机构
[1] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.0401419101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ramoplanin is a potent antibiotic, first disclosed in 1984, that acts by inhibiting bacterial cell-wall biosynthesis. The original ramoplanin complex was shown to consist of a mixture of three closely related compounds, ramoplanin A1-A3, of which ramoplanin A2 is the most abundant. The structure of ramoplanin A2 was unambiguously established first through a series of extensive spectroscopic studies, allowing complete stereochemical assignments and subsequently providing a minor reassignment of the side-chain double-bond stereochemistry and, most recently, through total synthesis of authentic material. Here we report the total syntheses of the aglycons of the minor components of the ramoplanin complex, A1 and A3, which unambiguously establish their structure and provide an expected structural revision for the lipid side-chain double-bond stereochemistry.
引用
收藏
页码:11977 / 11979
页数:3
相关论文
共 26 条
[1]   Vancomycin, teicoplanin, and ramoplanin: Synthetic and mechanistic studies [J].
Boger, DL .
MEDICINAL RESEARCH REVIEWS, 2001, 21 (05) :356-381
[2]   Total synthesis and comparative evaluation of luzopeptin A-C and quinoxapeptin A-C [J].
Boger, DL ;
Ledeboer, MW ;
Kume, M ;
Searcey, M ;
Jin, Q .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (49) :11375-11383
[3]   A-16686, A NEW ANTIBIOTIC FROM ACTINOPLANES .1. FERMENTATION, ISOLATION AND PRELIMINARY PHYSICOCHEMICAL CHARACTERISTICS [J].
CAVALLERI, B ;
PAGANI, H ;
VOLPE, G ;
SELVA, E ;
PARENTI, F .
JOURNAL OF ANTIBIOTICS, 1984, 37 (04) :309-317
[4]   RAMOPLANIN (A-16686), A NEW GLYCOLIPODEPSIPEPTIDE ANTIBIOTIC .3. STRUCTURE ELUCIDATION [J].
CIABATTI, R ;
KETTENRING, JK ;
WINTERS, G ;
TUAN, G ;
ZERILLI, L ;
CAVALLERI, B .
JOURNAL OF ANTIBIOTICS, 1989, 42 (02) :254-267
[5]  
Ciabatti R., 1989, European Patent, Patent No. [EP0337203B1, 0337203, 337203]
[6]  
ESPERSEN F, 1999, CURR OPIN ANTIINFECT, V1, P78
[7]   Rethinking ramoplanin: The role of substrate binding in inhibition of peptidoglycan biosynthesis [J].
Helm, JS ;
Chen, L ;
Walker, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (47) :13970-13971
[8]   ENDURACIDIN, A NEW ANTIBIOTIC .7. PRIMARY STRUCTURE OF PEPTIDE MOIETY [J].
HORI, M ;
IWASAKI, H ;
HORII, S ;
YOSHIDA, I ;
HONGO, T .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1973, 21 (06) :1175-1183
[9]   Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II [J].
Hu, YN ;
Helm, JS ;
Chen, L ;
Ye, XY ;
Walker, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (29) :8736-8737
[10]   ENDURACIDIN, A NEW ANTIBIOTIC .8. STRUCTURES OF ENDURACIDINS A AND B [J].
IWASAKI, H ;
HORII, S ;
ASAI, M ;
MIZUNO, K ;
UEYANAGI, J ;
MIYAKE, A .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1973, 21 (06) :1184-1191